Methadone is used to treat severe pain and to help people stop using heroin or other opioids by reducing cravings and withdrawal symptoms.[2] Dolophine is currently approved and in use across 33 indications[4].[1]
Dolophine is one of 679 small molecule programs targeting Premature Birth. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
540 competitors in Chronic Kidney Disease
Dolophine
Epogen
Uloric
Sovaldi
Lorelco
Activase
Miochol
Epoetin Beta
Januvia
Baraclude
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 1, 1982
METHADOSE
NDA NDA017116
Jan 1, 1982
METHADONE HYDROCHLORIDE
NDA NDA021624
Jan 1, 1982
METHADONE HYDROCHLORIDE
NDA NDA006383
Jan 1, 1982
DOLOPHINE HYDROCHLORIDE
NDA NDA006134
Jan 1, 1982
WESTADONE
NDA NDA017108
Jan 1, 1982
METHADONE HYDROCHLORIDE
NDA NDA017058
Sources
Details